D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAM
651
AA Mission Acquisition Corp.
AAM
$461M
| $17.8M | 0.02% |
1,707,750
+57,750
| +4% | +$602K |
|
652
Evolent Health
EVH
$1.16B
| $17.8M | 0.02% |
1,879,000
+1,255,929
| +202% | +$11.9M |
|
653
Omnicom Group
OMC
$15.3B
| $17.8M | 0.02% |
214,239
+173,984
| +432% | +$14.4M |
|
654
Visteon
VC
$3.51B
| $17.8M | 0.02% |
228,823
-50,603
| -18% | -$3.93M |
|
655
Anywhere Real Estate
HOUS
$729M
| $17.8M | 0.02% |
5,331,571
-93,834
| -2% | -$312K |
|
656
IDT Corp
IDT
$1.65B
| $17.7M | 0.02% |
345,773
-5,815
| -2% | -$298K |
|
|
VRN
657
DELISTED
Veren
VRN
| $17.7M | 0.02% |
2,673,791
+1,221,900
| +84% | +$8.08M |
|
658
EnerSys
ENS
$3.92B
| $17.6M | 0.02% |
192,465
-6,607
| -3% | -$605K |
|
659
Newmont
NEM
$83.4B
| $17.6M | 0.02% |
364,767
+245,921
| +207% | +$11.9M |
|
660
Norwegian Cruise Line
NCLH
$11.5B
| $17.6M | 0.02% |
928,333
-3,563,311
| -79% | -$67.6M |
|
|
EQV
661
EQV Ventures Acquisition Corp.
EQV
$462M
| $17.5M | 0.02% |
1,732,500
| – | – |
|
|
ANSC
662
Agriculture & Natural Solutions Acquisition Corp
ANSC
$470M
| $17.5M | 0.02% |
1,638,750
| – | – |
|
663
Wabash National
WNC
$470M
| $17.5M | 0.02% |
1,581,871
+522,197
| +49% | +$5.77M |
|
664
Yelp
YELP
$2B
| $17.3M | 0.02% |
468,090
-386,810
| -45% | -$14.3M |
|
665
CyberArk
CYBR
$23.6B
| $17.3M | 0.02% |
51,243
+24,478
| +91% | +$8.27M |
|
666
10x Genomics
TXG
$1.68B
| $17.3M | 0.02% |
1,982,263
+763,665
| +63% | +$6.67M |
|
667
Nu Skin
NUS
$570M
| $17.3M | 0.02% |
2,383,250
+131,898
| +6% | +$958K |
|
|
FL
668
DELISTED
Foot Locker
FL
| $17.1M | 0.02% |
1,213,125
+887,422
| +272% | +$12.5M |
|
669
Teledyne Technologies
TDY
$25.5B
| $17.1M | 0.02% |
34,326
+739
| +2% | +$368K |
|
670
Prestige Consumer Healthcare
PBH
$3.24B
| $17M | 0.02% |
197,193
+57,089
| +41% | +$4.91M |
|
671
LCI Industries
LCII
$2.55B
| $16.9M | 0.02% |
+193,391
| New | +$16.9M |
|
672
Xeris Biopharma Holdings
XERS
$1.25B
| $16.8M | 0.01% |
3,052,372
+1,688,920
| +124% | +$9.27M |
|
673
Orion
OEC
$592M
| $16.7M | 0.01% |
1,288,072
+359,647
| +39% | +$4.65M |
|
674
lululemon athletica
LULU
$19.6B
| $16.6M | 0.01% |
58,647
-224,292
| -79% | -$63.5M |
|
|
SAGE
675
DELISTED
Sage Therapeutics
SAGE
| $16.6M | 0.01% |
2,087,443
+1,367,338
| +190% | +$10.9M |
|